Minovia Therapeutics has provided an update on its planned combination with Launch One Acquisition Corp. The companies have entered into a definitive agreement, with the transaction expected to close in the first half of 2026. Upon completion, the combined entity will operate as Minovia Therapeutics and will trade on Nasdaq under a new ticker symbol.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Launch One Acquisition Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9624796) on January 13, 2026, and is solely responsible for the information contained therein.
Comments